ENTITY
Telix Pharmaceuticals

Telix Pharmaceuticals (TLX AU)

151
Analysis
Health Care • Australia
Telix Pharmaceuticals Limited operates as a biotechnology company. The Company develops and commercializes molecularly-targeted radiation therapy for the treatment of prostate, renal, and brain cancer. Telix Pharmaceuticals serves patients worldwide.
more
Exchange Announcement • 05 Oct 2026 05:23

Notification of cessation of securities - TLX

Exchange Announcement • 05 Oct 2026 05:22

Notification regarding unquoted securities - TLX

Exchange Announcement • 05 Oct 2026 05:22

Application for quotation of securities - TLX

Exchange Announcement • 30 Sep 2026 06:20

FDA Fast Track for BiPASS Pre Biopsy Prostate Imaging

Exchange Announcement • 25 Sep 2026 16:06

Change in substantial holding

x